AstraZeneca boosts early respiratory medicine with Pieris deal
Pieris will be responsible for advancing its preclinical lead candidate, PRS-060, into initial Phase I clinical trials in 2017
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Ajanta Pharma posts Rs 114 crore profit after tax in Q4 Fy 2017
The total comprehensive income grew 3 per cent at Rs 113 crore
India has at least 60 million to 80 million people with chronic respiratory disease
As we mark World Asthma Day on May 2, Dr Jaideep A Gogtay, Chief Medical Officer, Cipla explains to Viveka Roychowdhury why unlike…
Marksans Pharma receives GMP certificate
TGA, Department of Health, Australia issued the certificate for its Verna facility in Goa
Drug firm Marksans Pharma has received…
Sun Pharma Science Foundation recognises Indian scientists and young research scholars
Science Award winners announced for exemplary contribution and research in pharma and medical science
Syngene posts FY17 results : Registers a revenue of Rs 1272 crores
Syngene has recently posted its FY17 results. The company has posted a revenue of Rs 1272 crores and the EBITDA was up by 24 per…
Vyome Biosciences completes clinical study of VB-1953
The primary objective of the study is to compare efficacy, tolerability and safety of VB 1953 in Patients with Moderate to Severe…
ACG Inspection Systems acquires Croatian company IN2trace
As part of the acquisition, ACG Inspection Systems has acquired all the assets and IP of IN2trace, part of the IN2 group
DRL launches Ezetimibe and Simvastatin tablets in the US
They are a therapeutic equivalent generic version of Vytorin Tablets
H&T Presspart, Hovione Technology enter dry powder inhalation partnership
Unveil PowdAir Plus DPI designed for developing markets at RDD Europe 2017